Analysis of SHIP1 expression and activity in Crohn's disease patients.

SH2 domain containing inositol-5-phosphatase (SHIP1) is an important modulator of innate and adaptive immunity. In mice, loss of SHIP1 provokes severe ileitis resembling Crohn's disease (CD), as a result of deregulated immune responses, altered cytokine production and intestinal fibrosis. Recen...

Full description

Bibliographic Details
Main Authors: Rajesh Somasundaram, Sandra Fernandes, Jasper J Deuring, Colin de Haar, Ernst J Kuipers, Lauran Vogelaar, Frank A Middleton, C Janneke van der Woude, Maikel P Peppelenbosch, William G Kerr, Gwenny M Fuhler
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2017-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC5540589?pdf=render
_version_ 1818683410879610880
author Rajesh Somasundaram
Sandra Fernandes
Jasper J Deuring
Colin de Haar
Ernst J Kuipers
Lauran Vogelaar
Frank A Middleton
C Janneke van der Woude
Maikel P Peppelenbosch
William G Kerr
Gwenny M Fuhler
author_facet Rajesh Somasundaram
Sandra Fernandes
Jasper J Deuring
Colin de Haar
Ernst J Kuipers
Lauran Vogelaar
Frank A Middleton
C Janneke van der Woude
Maikel P Peppelenbosch
William G Kerr
Gwenny M Fuhler
author_sort Rajesh Somasundaram
collection DOAJ
description SH2 domain containing inositol-5-phosphatase (SHIP1) is an important modulator of innate and adaptive immunity. In mice, loss of SHIP1 provokes severe ileitis resembling Crohn's disease (CD), as a result of deregulated immune responses, altered cytokine production and intestinal fibrosis. Recently, SHIP1 activity was shown to be correlated to the presence of a CD-associated single nucleotide polymorphism in ATG16L1. Here, we studied SHIP1 activity and expression in an adult cohort of CD patients.SHIP1 activity, protein and mRNA expression in peripheral blood mononuclear cells from CD patients in clinical remission were determined by Malachite green assay, Western blotting and qRT-PCR respectively. Genomic DNA was genotyped for ATG16L1 rs2241880.SHIP1 protein levels are profoundly diminished in a subset of patients; however, SHIP1 activity and expression are not correlated to ATG16L1 SNP status in this adult cohort.Aberrant SHIP1 activity can contribute to disease in a subset of adult CD patients, and warrants further investigation.
first_indexed 2024-12-17T10:34:18Z
format Article
id doaj.art-438601c795fd434ca47b09f3b310e90a
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-17T10:34:18Z
publishDate 2017-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-438601c795fd434ca47b09f3b310e90a2022-12-21T21:52:26ZengPublic Library of Science (PLoS)PLoS ONE1932-62032017-01-01128e018230810.1371/journal.pone.0182308Analysis of SHIP1 expression and activity in Crohn's disease patients.Rajesh SomasundaramSandra FernandesJasper J DeuringColin de HaarErnst J KuipersLauran VogelaarFrank A MiddletonC Janneke van der WoudeMaikel P PeppelenboschWilliam G KerrGwenny M FuhlerSH2 domain containing inositol-5-phosphatase (SHIP1) is an important modulator of innate and adaptive immunity. In mice, loss of SHIP1 provokes severe ileitis resembling Crohn's disease (CD), as a result of deregulated immune responses, altered cytokine production and intestinal fibrosis. Recently, SHIP1 activity was shown to be correlated to the presence of a CD-associated single nucleotide polymorphism in ATG16L1. Here, we studied SHIP1 activity and expression in an adult cohort of CD patients.SHIP1 activity, protein and mRNA expression in peripheral blood mononuclear cells from CD patients in clinical remission were determined by Malachite green assay, Western blotting and qRT-PCR respectively. Genomic DNA was genotyped for ATG16L1 rs2241880.SHIP1 protein levels are profoundly diminished in a subset of patients; however, SHIP1 activity and expression are not correlated to ATG16L1 SNP status in this adult cohort.Aberrant SHIP1 activity can contribute to disease in a subset of adult CD patients, and warrants further investigation.http://europepmc.org/articles/PMC5540589?pdf=render
spellingShingle Rajesh Somasundaram
Sandra Fernandes
Jasper J Deuring
Colin de Haar
Ernst J Kuipers
Lauran Vogelaar
Frank A Middleton
C Janneke van der Woude
Maikel P Peppelenbosch
William G Kerr
Gwenny M Fuhler
Analysis of SHIP1 expression and activity in Crohn's disease patients.
PLoS ONE
title Analysis of SHIP1 expression and activity in Crohn's disease patients.
title_full Analysis of SHIP1 expression and activity in Crohn's disease patients.
title_fullStr Analysis of SHIP1 expression and activity in Crohn's disease patients.
title_full_unstemmed Analysis of SHIP1 expression and activity in Crohn's disease patients.
title_short Analysis of SHIP1 expression and activity in Crohn's disease patients.
title_sort analysis of ship1 expression and activity in crohn s disease patients
url http://europepmc.org/articles/PMC5540589?pdf=render
work_keys_str_mv AT rajeshsomasundaram analysisofship1expressionandactivityincrohnsdiseasepatients
AT sandrafernandes analysisofship1expressionandactivityincrohnsdiseasepatients
AT jasperjdeuring analysisofship1expressionandactivityincrohnsdiseasepatients
AT colindehaar analysisofship1expressionandactivityincrohnsdiseasepatients
AT ernstjkuipers analysisofship1expressionandactivityincrohnsdiseasepatients
AT lauranvogelaar analysisofship1expressionandactivityincrohnsdiseasepatients
AT frankamiddleton analysisofship1expressionandactivityincrohnsdiseasepatients
AT cjannekevanderwoude analysisofship1expressionandactivityincrohnsdiseasepatients
AT maikelppeppelenbosch analysisofship1expressionandactivityincrohnsdiseasepatients
AT williamgkerr analysisofship1expressionandactivityincrohnsdiseasepatients
AT gwennymfuhler analysisofship1expressionandactivityincrohnsdiseasepatients